Di Nuzzo Private Wealth, Inc. Revolution Medicines, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $700 Million
- Q4 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 15 shares of RVMD stock, worth $1,016. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 6
150.0%
Holding current value
$1,016
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RVMD
# of Institutions
360Shares Held
195MCall Options Held
2.66MPut Options Held
945K-
Vanguard Group Inc Valley Forge, PA15.7MShares$1.06 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.6MShares$991 Million2.96% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$908 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.4MShares$769 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA9.81MShares$665 Million0.08% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $5.94B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...